Sosei Heptares scores $5m milestone payment from Pfizer
The Pharma Data
SEPTEMBER 29, 2020
The collaboration has leveraged Sosei’s StaR technology and Structure-based Drug Design (SBDD) capabilities to design oral small molecules that modulate different G protein-coupled receptor (GPCR) targets across multiple disease areas. Source link.
52 
Let's personalize your content